National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
from NDTV News - Topstories https://ift.tt/Fep8WDX
Saturday, 30 April 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment